January 9, 2017 / 7:55 PM / 6 months ago

BRIEF-Egalet receives FDA approval for Arymo ER

1 Min Read

Jan 9 (Reuters) - Egalet Corp

* Egalet receives fda approval for arymo er (morphine sulfate) c-ii, an extended-release morphine product formulated with abuse-deterrent properties for treatment of chronic pain

* Egalet -fda approval of arymo er triggered $40 million in new funding to egalet from second tranche of senior secured debt financing previously announced

* Egalet corp says u.s. Commercial launch of arymo er, utilizing egalet's established commercial infrastructure, is planned for q1 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below